Treatments For Lymphoma

Lymphoma treatments include a broad range of approaches, from standard chemotherapy to radioimmunotherapy and more.

'Lymphoma' is an umbrella term that loosely refers to several dozen independent categorical types and subtypes of cancers of the lymphatic system.

 

Drug treatments for Lymphoma

Among the most commonly used drugs are:

Antibody drug conjugates

Histone deacetylase inhibitors

  • Istodax (romidepsin)

Monoclonal antibodies

Therapeutic proteasome inhibitors

  • Velcade (bortezomib)

Radioimmunotherapy

When monoclonal antibodies are combined with a radioactive isotope, a radioimmunotherapeutic treatment is born. Two currently two exist:

Involved field radiation

Involved field radiation (IFT) is used in some cases of lymphoma, generally when there is evidence of a bulky mass that can be targeted by radiotherapists. This is not uncommon in early-stage cases of Hodgkin's lymphoma.

Hematopoietic stem cell transplantation

Hematopoietic stem cell transplantation (HSCT) is a somewhat risky procedure that involves the transplanting of stem cells or bone marrow into a patient in order to rebuild their immune system and blood cell production; the patient can receive their own banked marrow (autologous) or they can receive donor marrow (allogenic). HSCT is generally considered the last line of therapy against a lymphoma because of the serious and drastic nature of the procedure and the high levels of chemotherapy and radiation necessary.

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap